Tiansheng Pharmaceutical Group Co Ltd (002872) — Capital Reinvestment Ratio
Tiansheng Pharmaceutical Group Co Ltd (002872) has a Capital Reinvestment Ratio of 0.30x as of March 2025, meaning it reinvests 0% of its operating cash flow (CN¥31.79 Million) in capital expenditures (CN¥9.44 Million). Check Tiansheng Pharmaceutical Group Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tiansheng Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (2012–2024)
This chart tracks Tiansheng Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see 002872 cash flow conversion.
Annual Capital Reinvestment Ratio for Tiansheng Pharmaceutical Group Co Ltd (2012–2024)
Year-by-year Capital Reinvestment Ratio for Tiansheng Pharmaceutical Group Co Ltd from 2012 to 2024. See cash generation quality of Tiansheng Pharmaceutical Group Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.00x | CN¥50.15 Million | CN¥50.27 Million | ▲ +21.8% |
| 2022 | 0.82x | CN¥89.18 Million | CN¥73.42 Million | ▼ -86.3% |
| 2021 | 6.03x | CN¥18.97 Million | CN¥114.38 Million | ▲ +1134.1% |
| 2020 | 0.49x | CN¥189.75 Million | CN¥92.70 Million | ▼ -24.4% |
| 2019 | 0.65x | CN¥144.21 Million | CN¥93.24 Million | ▼ -57.5% |
| 2018 | 1.52x | CN¥153.99 Million | CN¥234.27 Million | ▲ +81.0% |
| 2016 | 0.84x | CN¥506.68 Million | CN¥425.96 Million | ▼ -34.7% |
| 2015 | 1.29x | CN¥213.54 Million | CN¥274.87 Million | ▼ -25.2% |
| 2014 | 1.72x | CN¥191.99 Million | CN¥330.32 Million | ▼ -22.3% |
| 2013 | 2.21x | CN¥57.06 Million | CN¥126.34 Million | ▲ +74.0% |
| 2012 | 1.27x | CN¥145.06 Million | CN¥184.63 Million | — |